The SARS-CoV-2/Influenza A+B/RSV/Adenovirus Antigen Combo Rapid Test (Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein, Influenza A, Influenza B, Respiratory Syncytial Virus(RSV) and Adenovirus antigens in human nasopharyngeal swab specimens from individuals with suspected SARS-CoV-2/ Influenza/ RSV/Adenovirus infection in conjunction with clinical presentation and the results of other laboratory tests.
Fast (15minutes)
Simple Operation (Less Training Required)
Objective (Results Read by Analyzer)
High Accuracy
| Product features | Parameters |
| Format | Cassette |
| Specimen | Nasopharyngeal Swab |
| Certificate | CE |
| Reading Time | 15 minutes |
| Storage Temperature | 2-30°C |
| Sensitivity | SARS-CoV-2: 96.4%; Influenza A+B: Type A(95.0%), Type B(92.9%); RSV: 94.3%; Adenovirus: 96.9% |
| Specificity | SARS-CoV-2: 99.1%; Influenza A+B: Type A(99.1%), Type B(99.1%); RSV: 96.2%; Adenovirus: 98.6% |
| Accuracy | SARS-CoV-2: 98.2%; Influenza A+B: Type A(98.4%), Type B(98.1%); RSV: 95.9%; Adenovirus: 98.4% |
| Cat. No. | Product | Specimen | Pack | Cut-off |
| IRT-R545 | SARS-CoV-2/Influenza A+B/RSV/Adenovirus Antigen Combo Rapid Test | Nasopharyngeal Swab |
